eli lilly glp-1 news Nails Oral Trial—Here's What It Means for LLY Eli Lilly and Company added

Triangular fibrocartilage disorders: injury patterns and treat- ment

CLINICAL APPLICATION OF GLP-1 IN LIPID METABOLISM AND ADIPOSE-RELATED DISORDERS Effects of glp-/glucose-dependent insulinotropic peptide dual agonists on lipid metabolism GLP-/glucose-dependent insulinotropic peptide (GIP) dual agonists are a new type of oral hypoglycemic drug, which can activate both GLP-1 and GIP incretin at the same time, thereby exerting a more comprehensive blood glucose control effect [125]

doi: 10.1016/S0140-6736(18)31773-2 [DOI] [PubMed] [Google Scholar] 90

A clinical trial involving 120 people with gut Candida and digestive symptoms found that what they ate may have significantly improved treatment results

The most common side effects are typically mild and short-lived, including injection site reactions such as irritation, itching, or redness